Publications by authors named "Prashant Pandya"

Claim this Profile
H
High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging.
Lija James, Charlie Diamond, Hussein Al-Mossawi, Anneli Andersson, Prashant Pandya

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable Monitoring of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Using Imaging: A Systematic Literature Review and Meta-Analysis on Measurement Repeatability.
Michael Ndaa, Prashant K Pandya, Jordan Swensson, Niharika Samala, Saima Ajaz

Endocr Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric magnetic resonance imaging may improve detection of patients with at-risk MASH: Real world experience in hepatology clinics.
Meaghan M Phipps, Tatiana Hage, Emily Truong, Ju Dong Yang, Lauren Nicolosi, Prashant Pandya

Dig Liver Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative MRI for Monitoring Metabolic Dysfunction-Associated Steatotic Liver Disease: A Test-Retest Repeatability Study.
Cayden Beyer, Anneli Andersson, Elizabeth Shumbayawonda, Naim Alkhouri, Ami Banerjee, Prashant Pandya

J Magn Reson Imaging· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Imaging Reveals Steatosis and Fibroinflammation in Multiple Organs in People With Type 2 Diabetes: A Real-World Study.
Charlie Diamond, Michele Pansini, Azlinda Hamid, Nicole Eichert, Prashant Pandya

Diabetes· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with post-transplant biliary strictures have significantly higher rates of liver transplant failure and rejection: A nationwide inpatient analysis.
Divyanshoo R Kohli, Madhav V Desai, Kevin F Kennedy, Prashant Pandya, Prateek Sharma

J Gastroenterol Hepatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation.
David E Kaplan, Rajni Mehta, Guadalupe Garcia-Tsao, Jeffrey Albrecht, Ayse Aytaman, Prashant Pandya

Contemp Clin Trials· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
gene predicts clinical recovery after sustained virological response in decompensated hepatitis C cirrhosis.
Winston Dunn, Anusha Vittal, Jie Zhao, Jianghua He, Shweta Chakraborty, Prashant Pandya

BMJ Open Gastroenterol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice.
Prashant Pandya, Fasiha Kanwal

Hepatol Commun· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of sustained virological response to chronic hepatitic C antiviral therapy on new onset diabetes mellitus type 2 after controlling for metabolic syndrome.
Prashant Pandya, Chaitanya Pant, Ryan Taylor, Olurinde Oni

J Investig Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis.
Sashidhar Manthravadi, Swathi Paleti, Prashant Pandya

Int J Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Early Discontinuation of Pegylated Interferon for Reasons Other Than Lack of Efficacy in United States Veterans With Chronic Hepatitis C.
Joanne LaFleur, Robert Hoop, Eli Korner, Scott DuVall, Timothy Morgan, Prashant Pandya

Gastroenterol Nurs· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002-2012.
C Pant, B S Jani, M Desai, A Deshpande, Prashant Pandya

J Investig Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained virologic response and other potential genotype-specific roles of statins among patients with hepatitis C-related chronic liver diseases.
Prashant Pandya, Fadi Rzouq, Olurinde Oni

Clin Res Hepatol Gastroenterol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department visits related to Clostridium difficile infection: results from the nationwide emergency department sample, 2006 through 2010.
Chaitanya Pant, Thomas J Sferra, Mojtaba Olyaee, Richard Gilroy, Michael P Anderson, Prashant K Pandya

Acad Emerg Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department visits related to cirrhosis: a retrospective study of the nationwide emergency department sample 2006 to 2011.
Chaitanya Pant, Mojtaba Olyaee, Richard Gilroy, Prashant K Pandya, Jody C Olson

Medicine (Baltimore)· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy.
Richard E Nelson, Robert Hoop, Eli Korner, Scott DuVall, Candace L Hayden, Prashant Pandya

Ann Pharmacother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rates of early treatment discontinuation in hepatitis C-infected US veterans.
Joanne LaFleur, Robert Hoop, Timothy Morgan, Scott L DuVall, Prashant Pandya

BMC Res Notes· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin.
Stephen A Harrison, Fayez M Hamzeh, Jian Han, Prashant K Pandya, Muhammed Y Sheikh

Hepatology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C.
Gowtham A Rao, Prashant K Pandya

Gastroenterology· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion-related acute hepatic enzyme elevation: a new disease entity?
Jagdish S Nachnani, Fadi Hamid, Prashant Pandya, Wendell Clarkston, Laura M Alba

Eur J Gastroenterol Hepatol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
Jagdish S Nachnani, Gowtham A Rao, Deepti Bulchandani, Prashant K Pandya, Laura M Alba

Ann Hematol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance, hepatitis C, and liver transplantation.
Mazen Alsatie, Prashant Pandya, Naga P Chalasani

Liver Transpl· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe thrombocytopenia due to hypersplenism successfully treated with partial splenic embolization in preoperative management.
Amar G Pinto, Jan Namyslowski, Prashant Pandya

South Med J· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?
Naga Chalasani, David W Crabb, Oscar W Cummings, Paul Y Kwo, Ali Asghar, Prashant K Pandya

Am J Gastroenterol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis